semaglutide weight loss program seattle Wegovy (Semaglutide) in Semaglutide Weight Loss Program Flyer

Glycine acts as an inhibitory neurotransmitter and NMDA-receptor co-agonist

Source: Eli Lilly press release, December 2025 Phase 2 Results: Obesity Trial (NEJM 2023) The Phase 2 obesity trial enrolled 338 adults without diabetes and tested multiple dose levels over 48 weeks

The timing correlation between GI symptoms and palpitations is often revealing

Ginger tea before or after meals can partially counteract the gastric emptying delay caused by semaglutide

Throughout your journey, we continuously monitor your progress with regular InBody scans, ensuring you receive the personalized care and support you deserve

What is clear is that active, strategic management of your protocol, rather than passive waiting, produces the best outcomes during stall periods